Tissue-engineered kidney disease models

Advanced Drug Delivery Reviews

Volumn 69-70, Issue , 2014, Pages 67-80

  DesRochers, Teresa M ^a   Palma, Erica ^a   Kaplan, David L ^a  

^a Tufts University   (United States)

Author keywords

3D tissues; Acute kidney injury; Chronic kidney disease; Drug induced nephrotoxicity; Glomerulus; Microfluidics; Polycystic kidney disease; Renal; Renal cell carcinoma; Renal fibrosis

Indexed keywords

CELL CULTURE; DIAGNOSIS; DISEASES; MICROFLUIDICS;

3-D TISSUES; ACUTE KIDNEY INJURY; CHRONIC KIDNEY DISEASE; GLOMERULUS; NEPHROTOXICITY; POLYCYSTIC KIDNEY DISEASE; RENAL; RENAL CELL CARCINOMA; RENAL FIBROSIS;

TISSUE;

ANIMAL CELL; BIOREACTOR; DISEASE MODEL; DRUG DEVELOPMENT; GLOMERULUS; HUMAN; HUMAN CELL; HYDROGEL; KIDNEY CARCINOMA; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY POLYCYSTIC DISEASE; MICROFLUIDICS; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; ANIMAL; BIOLOGICAL MODEL; CULTURE TECHNIQUE; DRUG SCREENING; KIDNEY DISEASES; PATHOLOGY; PROCEDURES; TRANSFORMED CELL LINE; TRENDS;

URINARY TRACT AGENT;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TRANSFORMED; DRUG EVALUATION, PRECLINICAL; HUMANS; KIDNEY DISEASES; MODELS, BIOLOGICAL; RENAL AGENTS; TISSUE ENGINEERING;

EID: 84899957937     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.12.002     Document Type: Review

References (142)

1. Gibbons M.C., Foley M.A., Cardinal K.O. Thinking inside the box: keeping tissue-engineered constructs in vitro for use as preclinical models. Tissue Eng. Part B Rev. 2013, 19:14-30.
2. Olson H., Betton G., Robinson D., Thomas K., Monro A., Kolaja G., Lilly P., Sanders J., Sipes G., Bracken W., Dorato M., Van D.K., Smith P., Berger B., Heller A. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol. 2000, 32:56-67.
3. Knight A. Systematic reviews of animal experiments demonstrate poor contributions toward human healthcare. Rev. Recent Clin. Trials 2008, 3:89-96.
4. Hartung T. Three Rs potential in the development and quality control of pharmaceuticals. ALTEX 2001, 18(Suppl. 1):3-13.
5. Hartung T., Bremer S., Casati S., Coecke S., Corvi R., Fortaner S., Gribaldo L., Halder M., Roi A.J., Prieto P., Sabbioni E., Worth A., Zuang V. ECVAM's response to the changing political environment for alternatives: consequences of the European Union chemicals and cosmetics policies. Altern. Lab. Anim. 2003, 31:473-481.
6. Desrochers T.M., Suter L., Roth A., Kaplan D.L. Bioengineered 3D human kidney tissue, a platform for the determination of nephrotoxicity. PLoS One 2013, 8:e59219.
7. Segal N., Andriani F., Pfeiffer L., Kamath P., Lin N., Satyamurthy K., Egles C., Garlick J.A. The basement membrane microenvironment directs the normalization and survival of bioengineered human skin equivalents. Matrix Biol. 2008, 27:163-170.
8. Mueller D., Kramer L., Hoffmann E., Klein S., Noor F. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies. Toxicol. In Vitro 2013, 28:104-112.
9. Mulhall H.J., Hughes M.P., Kazmi B., Lewis M.P., Labeed F.H. Epithelial cancer cells exhibit different electrical properties when cultured in 2D and 3D environments. Biochim. Biophys. Acta 2013, 1830:5136-5141.
10. Krause S., Maffini M.V., Soto A.M., Sonnenschein C. A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. Tissue Eng. Part C Methods 2008, 14:261-271.
11. Desrochers T.M., Shamis Y., lt-Holland A., Kudo Y., Takata T., Wang G., Jackson-Grusby L., Garlick J.A. The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma. Epigenetics 2012, 7.
12. Shimony N., Gorodetsky R., Marx G., Gal D., Rivkin R., Ben-Ari A., Landsman A., Haviv Y.S. Fibrin microbeads (FMB) as a 3D platform for kidney gene and cell therapy. Kidney Int. 2006, 69:625-633.
13. Subramanian B., Rudym D., Cannizzaro C., Perrone R., Zhou J., Kaplan D.L. Tissue-engineered three-dimensional in vitro models for normal and diseased kidney. Tissue Eng. Part A 2010, 16:2821-2831.
14. Smith P.L., Buffington D.A., Humes H.D. Kidney epithelial cells. Methods Enzymol. 2006, 419:194-207.
15. Boogaard P.J., Nagelkerke J.F., Mulder G.J. Renal proximal tubular cells in suspension or in primary culture as in vitro models to study nephrotoxicity. Chem. Biol. Interact. 1990, 76:251-291.
16. Shimazui T., Schalken J.A., Kawai K., Kawamoto R., Van B.A., Oosterwijk E., Akaza H. Role of complex cadherins in cell-cell adhesion evaluated by spheroid formation in renal cell carcinoma cell lines. Oncol. Rep. 2004, 11:357-360.
17. Kim Y.K., Ko S.H., Woo J.S., Lee S.H., Jung J.S. Difference in H2O2 toxicity between intact renal tubules and cultured proximal tubular cells. Biochem. Pharmacol. 1998, 56:489-495.
18. Vickers A.E., Fisher R.L. Evaluation of drug-induced injury and human response in precision-cut tissue slices. Xenobiotica 2013, 43:29-40.
19. Cruz R.H., Gumbleton M., Nicholls P.J. In vitro assessment of cephaloridine nephrotoxicity: comparison of renal cortical slice and renal tubule fragment techniques. J. Pharmacol. Methods 1988, 19:185-192.
20. Sprenger A., Kuttner V., Biniossek M.L., Gretzmeier C., Boerries M., Mack C., Has C., Bruckner-Tuderman L., Dengjel J. Comparative quantitation of proteome alterations induced by aging or immortalization in primary human fibroblasts and keratinocytes for clinical applications. Mol. Biosyst. 2010, 6:1579-1582.
21. Lipps C., May T., Hauser H., Wirth D. Eternity and functionality - rational access to physiologically relevant cell lines. Biol. Chem. 2013, 394:1637-1648.
22. Detrisac C.J., Sens M.A., Garvin A.J., Spicer S.S., Sens D.A. Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int. 1984, 25:383-390.
23. Racusen L.C., Monteil C., Sgrignoli A., Lucskay M., Marouillat S., Rhim J.G., Morin J.P. Cell lines with extended in vitro growth potential from human renal proximal tubule: characterization, response to inducers, and comparison with established cell lines. J. Lab. Clin. Med. 1997, 129:318-329.
24. Orosz D.E., Woost P.G., Kolb R.J., Finesilver M.B., Jin W., Frisa P.S., Choo C.K., Yau C.F., Chan K.W., Resnick M.I., Douglas J.G., Edwards J.C., Jacobberger J.W., Hopfer U. Growth, immortalization, and differentiation potential of normal adult human proximal tubule cells. In Vitro Cell. Dev. Biol. Anim. 2004, 40:22-34.
25. Cummings B.S., Lasker J.M., Lash L.H. Expression of glutathione-dependent enzymes and cytochrome P450s in freshly isolated and primary cultures of proximal tubular cells from human kidney. J. Pharmacol. Exp. Ther. 2000, 293:677-685.
26. Ryan M.J., Johnson G., Kirk J., Fuerstenberg S.M., Zager R.A., Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 1994, 45:48-57.
27. Baer P.C., Geiger H. Human renal cells from the thick ascending limb and early distal tubule: characterization of primary isolated and cultured cells by reverse transcription polymerase chain reaction. Nephrology (Carlton) 2008, 13:316-321.
28. Tang S., Leung J.C., Lam C.W., Lai F.M., Chan T.M., Lai K.N. In vitro studies of aquaporins 1 and 3 expression in cultured human proximal tubular cells: upregulation by transferrin but not albumin. Am. J. Kidney Dis. 2001, 38:317-330.
29. Gunness P., Aleksa K., Kosuge K., Ito S., Koren G. Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity. Can. J. Physiol. Pharmacol. 2010, 88:448-455.
30. Wu Y., Connors D., Barber L., Jayachandra S., Hanumegowda U.M., Adams S.P. Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds. Toxicol. In Vitro 2009, 23:1170-1178.
31. Zager R.A., Johnson A.C., Geballe A. Gentamicin suppresses endotoxin-driven TNF-alpha production in human and mouse proximal tubule cells. Am. J. Physiol. Renal Physiol. 2007, 293:F1373-F1380.
32. Wei Z., Amponsah P.K., Al-Shatti M., Nie Z., Bandyopadhyay B.C. Engineering of polarized tubular structures in a microfluidic device to study calcium phosphate stone formation. Lab Chip 2012, 12:4037-4040.
33. Kher R., Sha E.C., Escobar M.R., Andreoli E.M., Wang P., Xu W.M., Wandinger-Ness A., Bacallao R.L. Ectopic expression of cadherin 8 is sufficient to cause cyst formation in a novel 3D collagen matrix renal tubule culture. Am. J. Physiol. Cell Physiol. 2011, 301:C99-C105.
34. Jang K.J., Mehr A.P., Hamilton G.A., McPartlin L.A., Chung S., Suh K.Y., Ingber D.E. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr. Biol. (Camb.) 2013, 5:1119-1129.
35. Wieser M., Stadler G., Jennings P., Streubel B., Pfaller W., Ambros P., Riedl C., Katinger H., Grillari J., Grillari-Voglauer R. hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am. J. Physiol. Renal Physiol. 2008, 295:F1365-F1375.
36. Hewitson T.D., Grimwood L. Immuno and lectin histochemistry for renal light microscopy. Methods Mol. Biol. 2009, 466:133-147.
37. Truong L.D., Phung V.T., Yoshikawa Y., Mattioli C.A. Glycoconjugates in normal human kidney. A histochemical study using 13 biotinylated lectins. Histochemistry 1988, 90:51-60.
38. Xia Y., Nivet E., Sancho-Martinez I., Gallegos T., Suzuki K., Okamura D., Wu M.Z., Dubova I., Esteban C.R., Montserrat N., Campistol J.M., Belmonte J.C. Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells. Nat. Cell Biol. 2013, 15:1507-1515.
39. Montserrat N., Ramirez-Bajo M.J., Xia Y., Sancho-Martinez I., Moya-Rull D., Miquel-Serra L., Yang S., Nivet E., Cortina C., Gonzalez F., Izpisua Belmonte J.C., Campistol J.M. Generation of induced pluripotent stem cells from human renal proximal tubular cells with only two transcription factors, OCT4 and SOX2. J. Biol. Chem. 2012, 287:24131-24138.
40. Wang A.Z., Wang J.C., Ojakian G.K., Nelson W.J. Determinants of apical membrane formation and distribution in multicellular epithelial MDCK cysts. Am. J. Physiol. 1994, 267:C473-C481.
41. Chung I.M., Enemchukwu N.O., Khaja S.D., Murthy N., Mantalaris A., Garcia A.J. Bioadhesive hydrogel microenvironments to modulate epithelial morphogenesis. Biomaterials 2008, 29:2637-2645.
42. Manivannan S., Gleghorn J.P., Nelson C.M. Engineered tissues to quantify collective cell migration during morphogenesis. Methods Mol. Biol. 2012, 886:173-182.
43. Ibraghimov-Beskrovnaya O., Dackowski W.R., Foggensteiner L., Coleman N., Thiru S., Petry L.R., Burn T.C., Connors T.D., Van R.T., Bradley J., Qian F., Onuchic L.F., Watnick T.J., Piontek K., Hakim R.M., Landes G.M., Germino G.G., Sandford R., Klinger K.W. Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:6397-6402.
44. Bukanov N.O., Husson H., Dackowski W.R., Lawrence B.D., Clow P.A., Roberts B.L., Klinger K.W., Ibraghimov-Beskrovnaya O. Functional polycystin-1 expression is developmentally regulated during epithelial morphogenesis in vitro: downregulation and loss of membrane localization during cystogenesis. Hum. Mol. Genet. 2002, 11:923-936.
45. Choucha-Snouber L., Aninat C., Grsicom L., Madalinski G., Brochot C., Poleni P.E., Razan F., Guillouzo C.G., Legallais C., Corlu A., Leclerc E. Investigation of ifosfamide nephrotoxicity induced in a liver-kidney co-culture biochip. Biotechnol. Bioeng. 2013, 110:597-608.
46. Choucha S.L., Jacques S., Monge M., Legallais C., Leclerc E. Transcriptomic analysis of the effect of ifosfamide on MDCK cells cultivated in microfluidic biochips. Genomics 2012, 100:27-34.
47. Elberg G., Guruswamy S., Logan C.J., Chen L., Turman M.A. Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures. Cell Tissue Res. 2008, 331:495-508.
48. Moll S., Ebeling M., Weibel F., Farina A., raujo Del R.A., Hoflack J.C., Pomposiello S., Prunotto M. Epithelial cells as active player in fibrosis: findings from an in vitro model. PLoS One 2013, 8:e56575.
49. Rosines E., Johkura K., Zhang X., Schmidt H.J., Decambre M., Bush K.T., Nigam S.K. Constructing kidney-like tissues from cells based on programs for organ development: toward a method of in vitro tissue engineering of the kidney. Tissue Eng. Part A 2010, 16:2441-2455.
50. Astashkina A.I., Mann B.K., Prestwich G.D., Grainger D.W. Comparing predictive drug nephrotoxicity biomarkers in kidney 3-D primary organoid culture and immortalized cell lines. Biomaterials 2012, 33:4712-4721.
51. Astashkina A.I., Mann B.K., Prestwich G.D., Grainger D.W. A 3-D organoid kidney culture model engineered for high-throughput nephrotoxicity assays. Biomaterials 2012, 33:4700-4711.
52. Egles C., Garlick J.A., Shamis Y. Three-dimensional human tissue models of wounded skin. Methods Mol. Biol. 2010, 585:345-359.
53. Kural M.H., Billiar K.L. Regulating tension in three-dimensional culture environments. Exp. Cell Res. 2013, 319:2447-2459.
54. Yeung T., Georges P.C., Flanagan L.A., Marg B., Ortiz M., Funaki M., Zahir N., Ming W., Weaver V., Janmey P.A. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil. Cytoskeleton 2005, 60:24-34.
55. Sechler J.L., Corbett S.A., Wenk M.B., Schwarzbauer J.E. Modulation of cell-extracellular matrix interactions. Ann. N. Y. Acad. Sci. 1998, 857:143-154.
56. Grogan S.P., Chen X., Sovani S., Taniguchi N., Colwell C.W., Lotz M., D'Lima D. Influence of cartilage extracellular matrix molecules on cell phenotype and neocartilage formation. Tissue Eng. Part A 2013 (Epub ahead of print).
57. Grover C.N., Cameron R.E., Best S.M. Investigating the morphological, mechanical and degradation properties of scaffolds comprising collagen, gelatin and elastin for use in soft tissue engineering. J. Mech. Behav. Biomed. Mater. 2012, 10:62-74.
58. Subramanian B., Ko W.C., Yadav V., Desrochers T.M., Perrone R.D., Zhou J., Kaplan D.L. The regulation of cystogenesis in a tissue engineered kidney disease system by abnormal matrix interactions. Biomaterials 2012, 33:8383-8394.
59. Ross E.A., Williams M.J., Hamazaki T., Terada N., Clapp W.L., Adin C., Ellison G.W., Jorgensen M., Batich C.D. Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J. Am. Soc. Nephrol. 2009, 20:2338-2347.
60. Ross E.A., Abrahamson D.R., St J.P., Clapp W.L., Williams M.J., Terada N., Hamazaki T., Ellison G.W., Batich C.D. Mouse stem cells seeded into decellularized rat kidney scaffolds endothelialize and remodel basement membranes. Organogenesis 2012, 8:49-55.
61. Song J.J., Guyette J.P., Gilpin S.E., Gonzalez G., Vacanti J.P., Ott H.C. Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat. Med. 2013, 19:646-651.
62. Orlando G., Farney A.C., Iskandar S.S., Mirmalek-Sani S.H., Sullivan D.C., Moran E., AbouShwareb T., De C.P., Wood K.J., Stratta R.J., Atala A., Yoo J.J., Soker S. Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann. Surg. 2012, 256:363-370.
63. Sullivan D.C., Mirmalek-Sani S.H., Deegan D.B., Baptista P.M., AbouShwareb T., Atala A., Yoo J.J. Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials 2012, 33:7756-7764.
64. Nakayama K.H., Batchelder C.A., Lee C.I., Tarantal A.F. Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. Tissue Eng. Part A 2010, 16:2207-2216.
65. Nakayama K.H., Batchelder C.A., Lee C.I., Tarantal A.F. Renal tissue engineering with decellularized rhesus monkey kidneys: age-related differences. Tissue Eng. Part A 2011, 17:2891-2901.
66. Nakayama K.H., Lee C.C., Batchelder C.A., Tarantal A.F. Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds. PLoS One 2013, 8:e64134.
67. Huh D., Hamilton G.A., Ingber D.E. From 3D cell culture to organs-on-chips. Trends Cell Biol. 2011, 21:745-754.
68. Duan Y., Gotoh N., Yan Q., Du Z., Weinstein A.M., Wang T., Weinbaum S. Shear-induced reorganization of renal proximal tubule cell actin cytoskeleton and apical junctional complexes. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11418-11423.
69. Essig M., Terzi F., Burtin M., Friedlander G. Mechanical strains induced by tubular flow affect the phenotype of proximal tubular cells. Am. J. Physiol. Renal Physiol. 2001, 281:F751-F762.
70. Cai Z., Xin J., Pollock D.M., Pollock J.S. Shear stress-mediated NO production in inner medullary collecting duct cells. Am. J. Physiol. Renal Physiol. 2000, 279:F270-F274.
71. Liu W., Xu S., Woda C., Kim P., Weinbaum S., Satlin L.M. Effect of flow and stretch on the [Ca2+]i response of principal and intercalated cells in cortical collecting duct. Am. J. Physiol. Renal Physiol. 2003, 285:F998-F1012.
72. Baudoin R., Griscom L., Monge M., Legallais C., Leclerc E. Development of a renal microchip for in vitro distal tubule models. Biotechnol. Prog. 2007, 23:1245-1253.
73. Jang K.J., Suh K.Y. A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells. Lab Chip 2010, 10:36-42.
74. Gao X., Tanaka Y., Sugii Y., Mawatari K., Kitamori T. Basic structure and cell culture condition of a bioartificial renal tubule on chip towards a cell-based separation microdevice. Anal. Sci. 2011, 27:907-912.
75. Frohlich E.M., Alonso J.L., Borenstein J.T., Zhang X., Arnaout M.A., Charest J.L. Topographically-patterned porous membranes in a microfluidic device as an in vitro model of renal reabsorptive barriers. Lab Chip 2013, 13:2311-2319.
76. Mu X., Zheng W., Xiao L., Zhang W., Jiang X. Engineering a 3D vascular network in hydrogel for mimicking a nephron. Lab Chip 2013, 13:1612-1618.
77. Praetorius H.A., Spring K.R. Removal of the MDCK cell primary cilium abolishes flow sensing. J. Membr. Biol. 2003, 191:69-76.
78. Praetorius H.A., Spring K.R. The renal cell primary cilium functions as a flow sensor. Curr. Opin. Nephrol. Hypertens. 2003, 12:517-520.
79. Joly D., Hummel A., Ruello A., Knebelmann B. Ciliary function of polycystins: a new model for cystogenesis. Nephrol. Dial. Transplant. 2003, 18:1689-1692.
80. Harris P.C., Torres V.E. Polycystic kidney disease. Annu. Rev. Med. 2009, 60:321-337.
81. Grantham J.J. Clinical practice. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 2008, 359:1477-1485.
82. Torres V.E., Harris P.C. Autosomal dominant polycystic kidney disease: the last 3years. Kidney Int. 2009, 76:149-168.
83. Gallagher A.R., Germino G.G., Somlo S. Molecular advances in autosomal dominant polycystic kidney disease. Adv. Chronic Kidney Dis. 2010, 17:118-130.
84. Grantham J.J., Uchic M., Cragoe E.J., Kornhaus J., Grantham J.A., Donoso V., Mangoo-Karim R., Evan A., McAteer J. Chemical modification of cell proliferation and fluid secretion in renal cysts. Kidney Int. 1989, 35:1379-1389.
85. Mangoo-Karim R., Uchic M.E., Grant M., Shumate W.A., Calvet J.P., Park C.H., Grantham J.J. Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. FASEB J. 1989, 3:2629-2632.
86. Li H., Findlay I.A., Sheppard D.N. The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors. Kidney Int. 2004, 66:1926-1938.
87. Orellana S.A., Marfella-Scivittaro C. Distinctive cyclic AMP-dependent protein kinase subunit localization is associated with cyst formation and loss of tubulogenic capacity in Madin-Darby canine kidney cell clones. J. Biol. Chem. 2000, 275:21233-21240.
88. Qian F., Watnick T.J., Onuchic L.F., Germino G.G. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996, 87:979-987.
89. Liu B., Li C., Liu Z., Dai Z., Tao Y. Increasing extracellular matrix collagen level and MMP activity induces cyst development in polycystic kidney disease. BMC Nephrol. 2012, 13:109.
90. Nakamura T., Ushiyama C., Suzuki S., Ebihara I., Shimada N., Koide H. Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease. Am. J. Nephrol. 2000, 20:32-36.
91. Bukanov N.O., Moreno S.E., Natoli T.A., Rogers K.A., Smith L.A., Ledbetter S.R., Oumata N., Galons H., Meijer L., Ibraghimov-Beskrovnaya O. CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD. Cell Cycle 2012, 11:4040-4046.
92. Zhou H., Gao J., Zhou L., Li X., Li W., Li X., Xia Y., Yang B. Ginkgolide B inhibits renal cyst development in in vitro and in vivo cyst models. Am. J. Physiol. Renal Physiol. 2012, 302:F1234-F1242.
93. Takiar V., Nishio S., Seo-Mayer P., King J.D., Li H., Zhang L., Karihaloo A., Hallows K.R., Somlo S., Caplan M.J. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:2462-2467.
94. Montesano R., Ghzili H., Carrozzino F., Rossier B.C., Feraille E. cAMP-dependent chloride secretion mediates tubule enlargement and cyst formation by cultured mammalian collecting duct cells. Am. J. Physiol. Renal Physiol. 2009, 296:F446-F457.
95. Wallace D.P. Cyclic AMP-mediated cyst expansion. Biochim. Biophys. Acta 2011, 1812:1291-1300.
96. Carone F.A., Nakamura S., Bacallao R., Nelson W.J., Khokha M., Kanwar Y.S. Impaired tubulogenesis of cyst-derived cells from autosomal dominant polycystic kidneys. Kidney Int. 1995, 47:861-868.
97. Wallace D.P., Grantham J.J., Sullivan L.P. Chloride and fluid secretion by cultured human polycystic kidney cells. Kidney Int. 1996, 50:1327-1336.
98. Sullivan L.P., Wallace D.P., Gover T., Welling P.A., Yamaguchi T., Maser R., Eppler J.W., Grantham J.J. Sulfonylurea-sensitive K(+) transport is involved in Cl(-) secretion and cyst trowth by cultured ADPKD cells. J. Am. Soc. Nephrol. 2002, 13:2619-2627.
99. Yamaguchi T., Reif G.A., Calvet J.P., Wallace D.P. Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells. Am. J. Physiol. Renal Physiol. 2010, 299:F944-F951.
100. Reif G.A., Yamaguchi T., Nivens E., Fujiki H., Pinto C.S., Wallace D.P. Tolvaptan inhibits ERK-dependent cell proliferation, Cl(-) secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin. Am. J. Physiol. Renal Physiol. 2011, 301:F1005-F1013.
101. Jansson K., Nguyen A.N., Magenheimer B.S., Reif G.A., Aramadhaka L.R., Bello-Reuss E., Wallace D.P., Calvet J.P., Blanco G. Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways. Am. J. Physiol. Renal Physiol. 2012, 303:F982-F990.
102. Buchholz B., Klanke B., Schley G., Bollag G., Tsai J., Kroening S., Yoshihara D., Wallace D.P., Kraenzlin B., Gretz N., Hirth P., Eckardt K.U., Bernhardt W.M. The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis. Nephrol. Dial. Transplant. 2011, 26:3458-3465.
103. Swenson-Fields K.I., Vivian C.J., Salah S.M., Peda J.D., Davis B.M., Van R.N., Wallace D.P., Fields T.A. Macrophages promote polycystic kidney disease progression. Kidney Int. 2013, 83:855-864.
104. Karihaloo A., Koraishy F., Huen S.C., Lee Y., Merrick D., Caplan M.J., Somlo S., Cantley L.G. Macrophages promote cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 2011, 22:1809-1814.
105. Watnick T.J., Germino G.G. Polycystic kidney disease: Polycystin-1 and polycystin-2-it's complicated. Nat. Rev. Nephrol. 2013, 9:249-250.
106. Low S.H., Vasanth S., Larson C.H., Mukherjee S., Sharma N., Kinter M.T., Kane M.E., Obara T., Weimbs T. Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev. Cell 2006, 10:57-69.
107. Weimbs T. Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1. Am. J. Physiol. Renal Physiol. 2007, 293:F1423-F1432.
108. Food and Drug Administration. Innovation or Stagnation: Challenge and opportunity on the critical path to new medical products. Ref Type: Report 2004, Food and Drug Administration, Washington, DC.
109. Choudhury D., Ahmed Z. Drug-associated renal dysfunction and injury. Nat. Clin. Pract. Nephrol. 2006, 2:80-91.
110. Fuchs T.C., Hewitt P. Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology. AAPS J. 2011, 13:615-631.
111. Pannu N., Nadim M.K. An overview of drug-induced acute kidney injury. Crit. Care Med. 2008, 36:S216-S223.
112. Zbinden G. Predictive value of animal studies in toxicology. Regul. Toxicol. Pharmacol. 1991, 14:167-177.
113. Knight A. Systematic reviews of animal experiments demonstrate poor human clinical and toxicological utility. Altern. Lab. Anim. 2007, 35:641-659.
114. Fry J.R., Wiebkin P., Kao J., Jones C.A., Gwynn J., Bridges J.W. A comparison of drug-metabolizing capability in isolated viable rat hepatocytes and renal tubule fragments. Xenobiotica 1978, 8:113-120.
115. Keane W.F., Welch R., Gekker G., Peterson P.K. Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells. Am. J. Pathol. 1987, 126:350-357.
116. Keane W.F., Gekker G., Schlievert P.M., Peterson P.K. Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1. Am. J. Pathol. 1986, 122:169-176.
117. Dieterle F., Sistare F., Goodsaid F., Papaluca M., Ozer J.S., Webb C.P., Baer W., Senagore A., Schipper M.J., Vonderscher J., Sultana S., Gerhold D.L., Phillips J.A., Maurer G., Carl K., Laurie D., Harpur E., Sonee M., Ennulat D., Holder D., ndrews-Cleavenger D., Gu Y.Z., Thompson K.L., Goering P.L., Vidal J.M., Abadie E., Maciulaitis R., Jacobson-Kram D., Defelice A.F., Hausner E.A., Blank M., Thompson A., Harlow P., Throckmorton D., Xiao S., Xu N., Taylor W., Vamvakas S., Flamion B., Lima B.S., Kasper P., Pasanen M., Prasad K., Troth S., Bounous D., Robinson-Gravatt D., Betton G., Davis M.A., Akunda J., McDuffie J.E., Suter L., Obert L., Guffroy M., Pinches M., Jayadev S., Blomme E.A., Beushausen S.A., Barlow V.G., Collins N., Waring J., Honor D., Snook S., Lee J., Rossi P., Walker E., Mattes W. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat. Biotechnol. 2010, 28:455-462.
118. Sung J.H., Shuler M.L. A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. Lab Chip 2009, 9:1385-1394.
119. Chang R., Emami K., Wu H., Sun W. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model. Biofabrication 2010, 2:1-11.
120. Lan S.F., Starly B. Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities. Toxicol. Appl. Pharmacol. 2011, 256:62-72.
121. Nakamura K., Mizutani R., Sanbe A., Enosawa S., Kasahara M., Nakagawa A., Ejiri Y., Murayama N., Miyamoto Y., Torii T., Kusakawa S., Yamauchi J., Fukuda M., Yamazaki H., Tanoue A. Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system. J. Biosci. Bioeng. 2011, 111:78-84.
122. Canton I., Cole D.M., Kemp E.H., Watson P.F., Chunthapong J., Ryan A.J., MacNeil S., Haycock J.W. Development of a 3D human in vitro skin co-culture model for detecting irritants in real-time. Biotechnol. Bioeng. 2010, 106:794-803.
123. Hu T., Khambatta Z.S., Hayden P.J., Bolmarcich J., Binder R.L., Robinson M.K., Carr G.J., Tiesman J.P., Jarrold B.B., Osborne R., Reichling T.D., Nemeth S.T., Aardema M.J. Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin. Toxicol. In Vitro 2010, 24:1450-1463.
124. Kirsch-Volders M., Decordier I., Elhajouji A., Plas G., Aardema M.J., Fenech M. In vitro genotoxicity testing using the micronucleus assay in cell lines, human lymphocytes and 3D human skin models. Mutagenesis 2011, 26:177-184.
125. El M.M., Laurent G., Mingeot-Leclercq M.P., Tulkens P.M. Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblasts. Toxicol. Sci. 2000, 56:229-239.
126. Charytan D., Kuntz R.E. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int. 2006, 70:2021-2030.
127. Zhou M.I., Foy R.L., Chitalia V.C., Zhao J., Panchenko M.V., Wang H., Cohen H.T. Jade-1, a candidate renal tumor suppressor that promotes apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11035-11040.
128. Koochekpour S., Jeffers M., Wang P.H., Gong C., Taylor G.A., Roessler L.M., Stearman R., Vasselli J.R., Stetler-Stevenson W.G., Kaelin W.G., Linehan W.M., Klausner R.D., Gnarra J.R., Vande Woude G.F. The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol. Cell Biol. 1999, 19:5902-5912.
129. Shimony N., Avrahami I., Gorodetsky R., Elkin G., Tzukert K., Zangi L., Levdansky L., Krasny L., Haviv Y.S. A 3D rotary renal and mesenchymal stem cell culture model unveils cell death mechanisms induced by matrix deficiency and low shear stress. Nephrol. Dial. Transplant. 2008, 23:2071-2080.
130. Ghosh A.K., Hurd T., Hildebrandt F. 3D spheroid defects in NPHP knockdown cells are rescued by the somatostatin receptor agonist octreotide. Am. J. Physiol. Renal Physiol. 2012, 303:F1225-F1229.
131. Grgic I., Campanholle G., Bijol V., Wang C., Sabbisetti V.S., Ichimura T., Humphreys B.D., Bonventre J.V. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int. 2012, 82:172-183.
132. Hildebrandt F., Zhou W. Nephronophthisis-associated ciliopathies. J. Am. Soc. Nephrol. 2007, 18:1855-1871.
133. Rodriguez-Barbero A., L'Azou B., Cambar J., Lopez-Novoa J.M. Potential use of isolated glomeruli and cultured mesangial cells as in vitro models to assess nephrotoxicity. Cell Biol. Toxicol. 2000, 16:145-153.
134. Gonzalez R., Redon P., Lakhdar B., Potaux L., Cambar J., Aparicio M. Cyclosporin nephrotoxicity assessed in isolated human glomeruli and cultured mesangial cells. Toxicol. In Vitro 1990, 4:391-395.
135. Potier M., L'Azou B., Cambar J. Isolated glomeruli and cultured mesangial cells as in vitro models to study immunosuppressive agents. Cell Biol. Toxicol. 1996, 12:263-270.
136. Saleem M.A., O'Hare M.J., Reiser J., Coward R.J., Inward C.D., Farren T., Xing C.Y., Ni L., Mathieson P.W., Mundel P. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 2002, 13:630-638.
137. Satchell S.C., Tasman C.H., Singh A., Ni L., Geelen J., von Ruhland C.J., O'Hare M.J., Saleem M.A., van den Heuvel L.P., Mathieson P.W. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int. 2006, 69:1633-1640.
138. Song B., Smink A.M., Jones C.V., Callaghan J.M., Firth S.D., Bernard C.A., Laslett A.L., Kerr P.G., Ricardo S.D. The directed differentiation of human iPS cells into kidney podocytes. PLoS One 2012, 7:e46453.
139. L'Azou B., Dubus I. Ohayon-Court, and J. Cambar, Human glomerular mesangial IP15 cell line as a suitable model for in vitro cadmium cytotoxicity studies. Cell Biol. Toxicol. 2007, 23:267-278.
140. Kitahara T., Hiromura K., Ikeuchi H., Yamashita S., Kobayashi S., Kuroiwa T., Kaneko Y., Ueki K., Nojima Y. Mesangial cells stimulate differentiation of endothelial cells to form capillary-like networks in a three-dimensional culture system. Nephrol. Dial. Transplant. 2005, 20:42-49.
141. Slater S.C., Beachley V., Hayes T., Zhang D., Welsh G.I., Saleem M.A., Mathieson P.W., Wen X., Su B., Satchell S.C. An in vitro model of the glomerular capillary wall using electrospun collagen nanofibres in a bioartificial composite basement membrane. PLoS One 2011, 6:e20802.
142. Miner J.H. The glomerular basement membrane. Exp. Cell Res. 2012, 318:973-978.